TrialBritish journal of clinical pharmacology2021

ONO-7684 a novel oral FXIa inhibitor: Safety, tolerability, pharmacokinetics and pharmacodynamics in a first-in-human study.

Dominic Beale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.